Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Head Neck. 2019 May 15;41(9):3114–3124. doi: 10.1002/hed.25803

Table 1.

Clinical characteristics of LSCC patients from whom UM-SCC cell lines were derived. UM-SCC-10A and 10B were derived from samples taken from the same patient at different times and sites. UM-SCC-81A and 81B were derived from two vocal cord masses resected in separate procedures. HPV-18 was detected in UM-SCC-105 by HPV-PCR mass array. HPV was not detected in other cell lines. Categories for which no data was available are marked with a dash; M, male; F, female; P, primary; R, recurrence; Met, metastasis; ICX, induction chemotherapy; S, surgery; RT, radiation therapy.

Cell Line Age Sex Clinical TNM Stage Specimen site Type of Lesion Previous Therapy HPV Status Smoking (pack-years) Alcohol
UMSCC-10A 57 M T3N0M0 III True Cord P None 20 Heavy
UMSCC-10B 58 M rT3N1M0 III Lymph Node Met S 20 Heavy
UMSCC-11A 65 M T2N2aM0 IV Epiglottis P ICX 35 Heavy
UMSCC-12 71 M T2N1M0 III Larynx R S, RT - -
UMSCC-13 60 M T3N0M0 III Stoma R RT,S 90 Heavy
UMSCC-17B 47 F T1N1M0 III Soft tissue-neck Met RT 40 None
UMSCC-23 36 F T2N0M0 II Supraglottis P None 48 Heavy
UMSCC-25 50 M rT3N2bM0 III Lymph Node Met RT,S,S Heavy Heavy
UMSCC-28 61 F T1N0M0 I True Cord P None 40 -
UMSCC-41 78 M T2N1M0 III Arytenoid P None 50 Moderate
UMSCC-46 58 F T2N2M0 IV Supraglottis R RT,S 60 Heavy
UMSCC-57 69 M - - Supraglottis - - - -
UMSCC-76 66 M T3N2cM0 IV Lymph Node Met ICX 40 Heavy
UMSCC-81A 53 M T2N0M0 II Anterior Commisure P None 100 Heavy
UMSCC-81B 58 M T2N0M0 II True Cord P None 100 Heavy
UMSCC-105 51 M T4N0M0 IV True Cord P None HPV-18 0 None